CHAPELGREEN PRACTICE
1 BEVAN WAY, CHAPELTOWN, SHEFFIELD
HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 54 | 62 | 87.1% | |
| HF 4 | 2011 | 48 | 58 | 82.8% | |
| HF 4 | 2012 | 45 | 57 | 78.9% | |
| HF 4 | 2013 | 54 | 60 | 90.0% | |
| HF004 | 2014 | 37 | 40 | 92.5% | |
| HF004 | 2015 | 37 | 42 | 88.1% | |
| HF004 | 2016 | 67 | 70 | 95.7% | |
| HF004 | 2017 | 71 | 80 | 88.8% | |
| HF004 | 2018 | 81 | 84 | 96.4% | |
| HF004 | 2019 | 93 | 100 | 93.0% | |
| HF004 | 2020 | 101 | 110 | 91.8% | |
| HF006 | 2021 | 118 | 136 | 86.8% | |
| HF006 | 2022 | 112 | 112 | 100.0% | |
| HF006 | 2023 | 105 | 108 | 97.2% |
